Treatment of patients with multiple primary malignant neoplasms (solid tumors and malignant diseases of the hematopoietic tissue) using systems for independent prolonged infusion therapy. Clinical observations-Reference-Cited by-同舟云学术

Treatment of patients with multiple primary malignant neoplasms (solid tumors and malignant diseases of the hematopoietic tissue) using systems for independent prolonged infusion therapy. Clinical observations

Published:2024-03-25 Issue:1 Volume:4 Page:71-77
ISSN:2782-6171
Container-title:MD-Onco
language:
Short-container-title:jour

Author:

Chekini D. A.¹^ORCID,Kutakov N. M.¹^ORCID,Sen’kina T. A.²,Zeynalova P. A.³^ORCID

Affiliation:

1. Clinical Hospital “Lapino” of the “Mother and Child” Group of companie

2. MGIMO-MED Medical University

3. Clinical Hospital “Lapino” of the “Mother and Child” Group of companie; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University

Abstract

Study of the problem of multiple primary malignant neoplasms (MPMNs) becomes more important and significant in modern clinical oncology. MPMN is a varied group of independent tumors of varying origin located in one or several organs. Due to introduction of single-use elastomeric microinfusion pumps into the clinical practice, continuous cyclical drug outpatient and in-hospital treatment of oncological patients with MPMNs can be performed. Significant successes of specific therapy led to increased lifespan of patients with MPMNs. Prolonged administration of drugs using infusion pump with set velocity allows to deliver cytostatics into the patient’s body in strictly controlled amounts. The article presents 2 clinical cases of effective antitumor treatment of patients with MPMNs using infusion pum

Publisher

Publishing House ABV Press

Reference13 articles.

1. Miller K.D., Nogueira L., Mariotto A.B. et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin 2019;69(5):363–85. DOI: 10.3322/caac.21565

2. Coyte A., Morrison D.S., McLoone P. Second primary cancer risk – the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study. BMC Сancer 2014;14:272. DOI: 10.1186/1471-2407-14-272

3. Cianfriglia F., Di Gregorio D.A., Manieri A. Multiple primary tumours in patients with oral squamous cell carcinoma. Oral Oncol 1999;35(2):157–63. DOI: 10.1016/s1368-8375(98)00105-5

4. International classification of diseases for oncology (ICD-O). 3rd edn., 1st revision. Ed. by A. Fritz, C. Percy, A. Jack et al. WHO, 2013. 252 p.

5. A review of the definition for multiple primary cancers in the United States. Workshop proceedings from December 4–6, 2002, in Princeton, New Jersey. Ed. by H.L. Howe. Springfield (IL): North American Association of Central Cancer Registries, 2003. 40 p.